Parexel Simplifies Access to Knowledge
A new report by the Economist Intelligence Unit (EIU) and commissioned by Parexel International Corporation reveals that new innovations in drug development have a positive impact on clinical trial timelines, likelihood of market launch, and inclusion on selected payer formularies.
